Akums Drugs and Pharmaceutical (AKUMS) — Working Capital to Net Assets Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Working Capital to Net Assets ratio of 77.7% as of September 2025. Working capital of Rs24.61 Billion (current assets of Rs32.93 Billion minus current liabilities of Rs8.33 Billion) is measured against net assets of Rs31.68 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Akums Drugs and Pharmaceutical's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Akums Drugs and Pharmaceutical Working Capital to Net Assets (2022–2025)
This chart shows how Akums Drugs and Pharmaceutical's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 77.7%, reflecting working capital of Rs24.61 Billion against net assets of Rs31.68 Billion INR. Check Akums Drugs and Pharmaceutical tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Akums Drugs and Pharmaceutical (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Akums Drugs and Pharmaceutical from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see AKUMS market cap overview.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.1% | Rs13.81 Billion | Rs30.64 Billion | Rs22.75 Billion | Rs8.94 Billion | ▼ -56.3 pp |
| 2024 | 101.4% | Rs7.30 Billion | Rs7.20 Billion | Rs19.41 Billion | Rs12.11 Billion | ▲ +10.3 pp |
| 2023 | 91.0% | Rs6.59 Billion | Rs7.23 Billion | Rs19.24 Billion | Rs12.66 Billion | ▼ -8.0 pp |
| 2022 | 99.0% | Rs6.19 Billion | Rs6.25 Billion | Rs18.92 Billion | Rs12.72 Billion | — |